Sign in

CIK 0001833769

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Hyperfine, Inc.

Sign in to watch
Ticker
HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 866-796-6767
Business address
351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
Former names
HealthCor Catalio Acquisition Corp.
  1. 4 Open-market sale Gen Counsel & Corp Secretary sold 1,891 shares at $1.45 ($2,742)
  2. 4 Open-market buy Director bought 64,213 shares at $1.48 ($95,164)
  3. 4 Open-market buy Director bought 303,137 shares at $1.46 ($441,671)
  4. 4 Open-market sale CMO and Chief Strategy Officer sold 4,846 shares at $2.02 ($9,789)
  5. 4 Open-market sale Gen Counsel & Corp Secretary sold 10,542 shares at $2.02 ($21,295)
  6. 4 Open-market buy Director bought 52,848 shares at $2.26 ($119,436)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award President and CEO acquired 649,350 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Commercial Officer acquired 96,875 shares (grant or award)
  16. 4 Grant or award Gen Counsel & Corp Secretary acquired 127,500 shares (grant or award)
  17. 4 Grant or award CMO and Chief Strategy Officer acquired 92,000 shares (grant or award)
  18. 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 127,167 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 5 of 8 · 144 filings